within Pharmacolibrary.Drugs.ATC.A;

model A09AB02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.7,
    Cl             = 0.0001,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0006,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0016666666666666668,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A09AB02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Betaine hydrochloride is a synthetic form of betaine, which is a naturally occurring compound found in beets and other foods. It has been used as a dietary supplement to increase stomach acidity, aid digestion, and sometimes as a methyl donor in metabolic disorders such as homocystinuria. Betaine hydrochloride is not broadly approved as a drug for any indication in most regulatory jurisdictions, and its use as a supplement has declined due to safety concerns.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic models or explicit PK parameters for betaine hydrochloride in humans could be identified. All values below are estimations based on the physicochemical properties of betaine and general assumptions about orally administered small, highly water-soluble molecules.</p><h4>References</h4><ol><li><p>Schwahn, BC, et al., &amp; Wendel, U (2003). Pharmacokinetics of oral betaine in healthy subjects and patients with homocystinuria. <i>British journal of clinical pharmacology</i> 55(1) 6–13. DOI:<a href=\"https://doi.org/10.1046/j.1365-2125.2003.01717.x\">10.1046/j.1365-2125.2003.01717.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/12534635/\">https://pubmed.ncbi.nlm.nih.gov/12534635</a></p></li><li><p>Imbard, A, et al., &amp; Schiff, M (2022). Efficacy and pharmacokinetics of betaine in CBS and cblC deficiencies: a cross-over randomized controlled trial. <i>Orphanet journal of rare diseases</i> 17(1) 417–None. DOI:<a href=\"https://doi.org/10.1186/s13023-022-02567-4\">10.1186/s13023-022-02567-4</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36376887/\">https://pubmed.ncbi.nlm.nih.gov/36376887</a></p></li><li><p>Simpson, M, &amp; Parrott, EL (1980). Oral and rectal absorption of chloral hydrate and its betaine complex. <i>Journal of pharmaceutical sciences</i> 69(2) 227–228. DOI:<a href=\"https://doi.org/10.1002/jps.2600690235\">10.1002/jps.2600690235</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7359335/\">https://pubmed.ncbi.nlm.nih.gov/7359335</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A09AB02;
